Alto Neuroscience, Inc. (ANRO) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ANRO Hot Sheet
Join SI Premium – FREE
Alto Neuroscience, Inc. (NYSE: ANRO) reported Q1 EPS of ($0.56), $0.01 better than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aletheia Capital Reiterates Sell Rating on Apple (AAPL), PT $250, 'we expect both gross and operating margins to contract'
- Grab Holdings (GRAB) Misses Q3 EPS by 5c; raises guidance
- Grifols, S.A. (GRFS) Reports Q3 results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
